CP 751,871 (Figitumumab)
A4021018
Phase 3 small_molecule terminated
Quick answer
CP 751,871 (Figitumumab) for Carcinoma, Large Cell is a Phase 3 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Carcinoma, Large Cell
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated